Genetic Engineering of Streptomyces natalensis VTCC-A-3245 to Improve Its Natamycin Production
Main Article Content
Abstract
Abstract: Natamycin, a polyene compound with broad-spectrum activity against yeasts and fungi, was firstly found in Streptomyces natalensis. Because of its low toxicity to mammalian cells, natamycin is widely used in food industry and medicine to prevent fungal growth. Although natamycin has been used worldwide, this antifungal compound has not been produced in Vietnam. One of the reasons is that we do not own any industrial-scale production strain. In order to develop such production strain, strain improvement must be involved. Therefore, we carried out the study “Genetic engineering of Streptomyces natalensis VTCC-A-3245 to improve its production of natamycin”. In this study, we introduced a copy of the gene pimM, a positive regulator gene in the natamycin biosynthetic pathway, into S. natalensis chromosome, hence boosting the expression of the structural genes, resulting in the increase of natamycin production. As a result, a recombinant pSET152 plasmid containing pimM was constructed and transformed successfully into E. coli ET12567. After conjugation, a S. natalensis mutant carrying an additional copy of pimM was obtained. The result showed that the level of natamycin produced by the S. natalensis mutant strain increased 3 fold compared to the S. natalensis wildtype strain.
Keywords: Streptomyces natalensis, natamycin, strain improvement, pimM.
References
[2] Mukesh, S. (2014), "Actinomycetes: Source, identification, and their applications", International Journal of Current Microbiology and Applied Sciences, 3, pp.801-832.
[3] Atta, H. M., Selim, S. M., and Zayed, M. S., (2012), "Natamycin antibiotic produced by Streptomyces sp.: Fermentation, purification and biological activities". Journal of American Science. 8(2): p. 469-475.
[4] Struyk, A.P., Hoette, I., Drost, G., Waisvisz, J.M., Van Eek, T., Hoogerheide, J.C., (1958), "Pimaricin, a new antifungal antibiotic". Antibiot. Annu. 5: p. 878–885.
[5] Brik, H., (1994), "Natamycin". Analytical Profiles of Drug Substances and Excipients. 23: p. 399-399.
[6] Te Welscher, Y. M., Van Leeuwen, M. R., De Kruijff, B., Dijksterhuis, J., and Breukink, E., (2012), "Polyene antibiotic that inhibits membrane transport proteins". Proceedings of the National Academy of Sciences. 109(28): p. 11156-11159.
[7] Tamehiro, N., Hosaka, T., Xu, J., Hu, H., Otake, N., and Ochi, K., (2003), "Innovative approach for improvement of an antibiotic-overproducing industrial strain of Streptomyces albus". Applied and environmental microbiology. 69(11): p. 6412-6417.
[8] Barrios-Gonzalez, J., Fernandez, F., and Tomasini, A., (2003), "Microbial secondary metabolites production and strain improvement". Indian Journal of Biotechnology. 2(3): p. 322-333.
[9] Olano, C., Lombó, F., Méndez, C., and Salas, J. A., (2008), "Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering". Metabolic engineering. 10(5): p. 281-292.
[10] Blaesing, F., Mühlenweg, A., Vierling, S., Ziegelin, G., Pelzer, S., and Lanka, E., (2005), "Introduction of DNA into actinomycetes by bacterial conjugation from E. coli—an evaluation of various transfer systems". Journal of biotechnology. 120(2): p. 146-161.
[11] Mazodier, P., Petter, R., and Thompson, C., (1989), "Intergeneric conjugation between Escherichia coli and Streptomyces species". Journal of Bacteriology. 171(6): p. 3583-3585.
[12] Kieser, T., Bibb, M., Buttner, M., Chater, K., and Hopwood, D., Practical Streptomyces Genetics. 2010, The John Innes Foundation, United Kingdom.
[13] Antón, N., Santos-Aberturas, J., Mendes, M. V., Guerra, S. M., Martín, J. F., and Aparicio, J. F., (2007), "PimM, a PAS domain positive regulator of pimaricin biosynthesis in Streptomyces natalensis". Microbiology. 153(9): p. 3174-3183.